Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine plus melatonin for prevention of delirium after coronary artery bypass graft surgery
IRCT20180909040979N7Phase 3Completed
- Sponsor
- Ahvaz Jundishapur University of Medical Sciences
- Start
- May 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in delirium comparing Dexmedetomidine + melatonin with Dexmedetomidine + placebo (2 arms). Primary endpoints: Delirium incidence and Intensity of delirium. Started May 2022; status: completed.
02
Drugs
dexmedetomidinemelatonin
03
Conditions
delirium
Beyond the preview
Go deeper on IRCT20180909040979N7.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180909040979N7.